<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3608713</article-id><article-id pub-id-type="pmid">23555691</article-id><article-id pub-id-type="publisher-id">PONE-D-12-31561</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0059525</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Biological Transport</subject></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Molecular Genetics</subject></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Streptococci</subject></subj-group></subj-group><subj-group><subject>Bacteriology</subject><subj-group><subject>Bacterial Biochemistry</subject><subject>Bacterial Physiology</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Functionally Cloned <italic>pdrM</italic> from <italic>Streptococcus pneumoniae</italic> Encodes a Na<sup>+</sup> Coupled Multidrug Efflux Pump</article-title><alt-title alt-title-type="running-head">A MATE-Type Drug Efflux Pump from <italic>S. pneumoniae</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hashimoto</surname><given-names>Kohei</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ogawa</surname><given-names>Wakano</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nishioka</surname><given-names>Toshihiro</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Tsuchiya</surname><given-names>Tomofusa</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="author-notes" rid="fn1">
<sup>&#x000a4;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kuroda</surname><given-names>Teruo</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">
<addr-line>Department of Molecular Microbiology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, Japan</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Webber</surname><given-names>Mark Alexander</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Birmingham, United Kingdom</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>wogawa@pharm.okayama-u.ac.jp</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Contributed as an adviser through all the experiments: TK WO. Taught practical experiments and gave practical suggestions to performing experiments: TK WO. Conceived and designed the experiments: TT TK. Performed the experiments: KH TN. Analyzed the data: KH TN. Contributed reagents/materials/analysis tools: KH TN WO. Wrote the paper: WO.</p></fn><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Department of Molecular Microbiology, College of Pharmaceutical Sciences, Ritsumeikan University, Noji-higashi, Kusatsu, Shiga, Japan</p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>26</day><month>3</month><year>2013</year></pub-date><volume>8</volume><issue>3</issue><elocation-id>e59525</elocation-id><history><date date-type="received"><day>4</day><month>10</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Hashimoto et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Hashimoto et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p>Multidrug efflux pumps play an important role as a self-defense system in bacteria. Bacterial multidrug efflux pumps are classified into five families based on structure and coupling energy: resistance&#x02212;nodulation&#x02212;cell division (RND), small multidrug resistance (SMR), major facilitator (MF), ATP binding cassette (ABC), and multidrug and toxic compounds extrusion (MATE). We cloned a gene encoding a MATE-type multidrug efflux pump from <italic>Streptococcus pneumoniae</italic> R6, and designated it <italic>pdrM</italic>. PdrM showed sequence similarity with NorM from <italic>Vibrio parahaemolyticus</italic>, YdhE from <italic>Escherichia coli,</italic> and other bacterial MATE-type multidrug efflux pumps. Heterologous expression of PdrM let to elevated resistance to several antibacterial agents, norfloxacin, acriflavine, and 4&#x02032;,6-diamidino-2-phenylindole (DAPI) in <italic>E. coli</italic> KAM32 cells. PdrM effluxes acriflavine and DAPI in a Na<sup>+</sup>- or Li<sup>+</sup>-dependent manner. Moreover, Na<sup>+</sup> efflux via PdrM was observed when acriflavine was added to Na<sup>+</sup>-loaded cells expressing <italic>pdrM</italic>. Therefore, we conclude that PdrM is a Na<sup>+</sup>/drug antiporter in <italic>S. pneumoniae</italic>. In addition to <italic>pdrM</italic>, we found another two genes, spr1756 and spr1877,that met the criteria of MATE-type by searching the <italic>S. pneumoniae</italic> genome database. However, cloned spr1756 and spr1877 did not elevate the MIC of any of the investigated drugs. mRNA expression of spr1756, spr1877, and <italic>pdrM</italic> was detected in <italic>S. pneumoniae</italic> R6 under laboratory growth conditions. Therefore, spr1756 and spr1877 are supposed to play physiological roles in this growth condition, but they may be unrelated to drug resistance.</p></abstract><funding-group><funding-statement>This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>
<italic>Streptococcus pneumoniae</italic> is the most common pathogenic bacterium in community-acquired pneumonia <xref rid="pone.0059525-Diaz1" ref-type="bibr">[1]</xref>, <xref rid="pone.0059525-Vainio1" ref-type="bibr">[2]</xref>, <xref rid="pone.0059525-Lagos1" ref-type="bibr">[3]</xref>, <xref rid="pone.0059525-Sousa1" ref-type="bibr">[4]</xref>, <xref rid="pone.0059525-Gentile1" ref-type="bibr">[5]</xref>. In Japan, it has been reported that <italic>S. pneumoniae</italic> is detected in 10&#x02013;36% of investigated episodes of community-acquired pneumonia <xref rid="pone.0059525-Bamba1" ref-type="bibr">[6]</xref>, <xref rid="pone.0059525-Tajima1" ref-type="bibr">[7]</xref>, <xref rid="pone.0059525-Yanagihara1" ref-type="bibr">[8]</xref>, <xref rid="pone.0059525-Umeki1" ref-type="bibr">[9]</xref>. This bacterium colonizes the upper respiratory tract and sometimes causes pneumonia, but it is also responsible for acute otitis media, bacteremia, and bacterial meningitis <xref rid="pone.0059525-Mitchell1" ref-type="bibr">[10]</xref>. &#x003b2;-lactams and macrolides are usually used to treat <italic>S. pneumoniae</italic> infections, but the recent increase in the prevalence of antibiotic-resistant <italic>S. pneumoniae</italic> is a serious problem in clinical sites worldwide <xref rid="pone.0059525-Yanagihara1" ref-type="bibr">[8]</xref>, <xref rid="pone.0059525-Jenkins1" ref-type="bibr">[11]</xref>, <xref rid="pone.0059525-Rantala1" ref-type="bibr">[12]</xref>, <xref rid="pone.0059525-Mera1" ref-type="bibr">[13]</xref>, <xref rid="pone.0059525-Song1" ref-type="bibr">[14]</xref>, <xref rid="pone.0059525-Imai1" ref-type="bibr">[15]</xref>, <xref rid="pone.0059525-Ishida1" ref-type="bibr">[16]</xref>.</p><p>The frequency of isolating penicillin-resistant <italic>S. pneumoniae</italic> (PRSP), including penicillin-intermediate resistant <italic>S. pneumoniae</italic> (PISP), is as high as 25&#x02013;50% in Japan <xref rid="pone.0059525-Hotomi1" ref-type="bibr">[17]</xref>, <xref rid="pone.0059525-Maekawa1" ref-type="bibr">[18]</xref>. This, in addition to emerging multidrug-resistant <italic>S. pneumoniae</italic> (MDRSP), makes therapy difficult.</p><p>Several mechanisms contribute to bacterial resistance to drugs: 1) inactivation of drugs by degradation or modification, 2) modification of drug targets, 3) emergence of a bypass mechanism that is not inhibited by drugs, 4) changes in membrane permeability for drugs, and 5) drug efflux from cells. Among these five mechanisms, drug efflux, especially multidrug efflux, is known to play an important role in multidrug resistance in bacteria <xref rid="pone.0059525-Piddock1" ref-type="bibr">[19]</xref>, <xref rid="pone.0059525-Sulavik1" ref-type="bibr">[20]</xref>, <xref rid="pone.0059525-Hsieh1" ref-type="bibr">[21]</xref>, <xref rid="pone.0059525-Morita1" ref-type="bibr">[22]</xref>.</p><p>Multidrug efflux pumps actively expel various chemical compounds, including antibiotics, dyes, and detergents. So far, three drug efflux pumps, PmrA <xref rid="pone.0059525-Gill1" ref-type="bibr">[23]</xref>, MefE <xref rid="pone.0059525-TaitKamradt1" ref-type="bibr">[24]</xref>, and PatAB <xref rid="pone.0059525-Marrer1" ref-type="bibr">[25]</xref> have been reported in <italic>S. pneumoniae</italic>. PmrA and MefE are classified as MF-type pumps and PatAB is an ABC-type efflux pump <xref rid="pone.0059525-Saier1" ref-type="bibr">[26]</xref>, <xref rid="pone.0059525-Boncoeur1" ref-type="bibr">[27]</xref>. However, more drug efflux pump genes are predicted to exist in the <italic>S. pneumoniae</italic> genome and remain uncharacterized (<ext-link ext-link-type="uri" xlink:href="http://www.streppneumoniae.com/">http://www.streppneumoniae.com/</ext-link>).</p><p>We found a new gene for multidrug resistance in <italic>S. pneumoniae</italic> by shot-gun cloning. The gene was predicted to encode a MATE-type efflux pump because of the similarity of its primary structure with known MATE-type efflux pumps <xref rid="pone.0059525-Kuroda1" ref-type="bibr">[28]</xref>.</p><p>The crystal structure of the MATE-type efflux pump, NorM from <italic>Vibrio cholerae</italic> was solved in 2010 and results showed that this protein possesses twelve transmembrane helices, composed of two bundles of six transmembrane helices (TMs 1&#x02013;6 and TMs 7&#x02013;12) <xref rid="pone.0059525-He1" ref-type="bibr">[29]</xref>. Coupling with Na<sup>+</sup> and substrate is an interesting characteristic of MATE-type efflux pumps, and this phenomenon has been reported in most MATE-type efflux pumps (<italic>e.g.</italic> NorM from <italic>V. parahaemolyticus</italic>
<xref rid="pone.0059525-Morita2" ref-type="bibr">[30]</xref>, VcmA from <italic>V. cholerae</italic> non-O1 <xref rid="pone.0059525-Huda1" ref-type="bibr">[31]</xref>, VmrA from <italic>V. parahaemolyticus</italic>
<xref rid="pone.0059525-Chen1" ref-type="bibr">[32]</xref>, VcrM from <italic>V. cholerae</italic> non-O1 <xref rid="pone.0059525-Huda2" ref-type="bibr">[33]</xref>, HmrM from <italic>Haemophilus influenzae</italic> Rd <xref rid="pone.0059525-Xu1" ref-type="bibr">[34]</xref>, and NorM from <italic>Neisseria gonorrhoeae</italic>
<xref rid="pone.0059525-Long1" ref-type="bibr">[35]</xref>). Here we report the characteristics of a novel MATE-type efflux pump from <italic>S. pneumoniae</italic>, including its Na<sup>+</sup> coupling ability.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Bacterial Strains and Growth</title><p>
<italic>S. pneumoniae</italic> R6 (ATCC number, BAA-255), which was purchased from the American Type Culture Collection, was used as a source of chromosomal DNA. <italic>S. pneumoniae</italic> was grown in brain heart infusion (BHI, Difco) at 37&#x000b0;C for 16 hr&#x0223c;24 hr without shaking. <italic>E. coli</italic> KAM32 (&#x00394;<italic>acrB</italic>, &#x00394;<italic>ydhE</italic>) <xref rid="pone.0059525-Chen1" ref-type="bibr">[32]</xref>, a drug-hypersusceptible strain, was used as a cloning host. <italic>E. coli</italic> was grown aerobically in LB broth at 37&#x000b0;C.</p></sec><sec id="s2b"><title>Cloning of the <italic>pdrM</italic> Gene</title><p>Chromosomal DNA was prepared from <italic>S. pneumoniae</italic> R6 by the method of Berns and Thomas <xref rid="pone.0059525-Berns1" ref-type="bibr">[36]</xref>. Chromosomal DNA was partially digested with <italic>Sau</italic>3AI, and fragments ranging in size from 3 to 10 kbp were separated by sucrose density gradient centrifugation. Plasmid pHY300PLK (Takara Co.) was digested with <italic>Bam</italic>HI, dephosphorylated with shrimp alkaline phosphatase (Roche Diagnostics K.K.), and then ligated to chromosomal DNA fragments with a Ligation-Convenience Kit (Nippon Gene Co.). Competent <italic>E. coli</italic> KAM32 cells were transformed with recombinant plasmids and incubated at 37&#x000b0;C for 48 h on LB plates containing an antimicrobial agent. We also used 10 &#x000b5;g/ml erythromycin and 10 &#x000b5;g/ml tetraphenylphosphonium chloride to clone drug efflux pump genes, but could not isolate any candidates. We isolated eight candidates from a plate containing 5 &#x000b5;g/ml acriflavine. Single colonies were isolated on the same medium as the selection medium, and plasmids were extracted from cells. <italic>E. coli</italic> KAM32 was re-transformed with the plasmids to confirm that it was responsible for the observed resistance to the antimicrobial agent used for the selection. Subsequently, restriction maps of candidate plasmids were determined.</p></sec><sec id="s2c"><title>PCR Cloning of Putative MATE Efflux Pump Genes</title><p>The <italic>pdrM</italic> gene was also cloned by PCR to compare its activity with the products of spr1756 and spr1877 under the same promoter. A DNA fragment containing the <italic>pdrM</italic>, spr1756, or spr1877 gene was amplified by PCR using <italic>S. pneumoniae</italic> R6 chromosomal DNA as a template. Primers used for gene cloning are listed in <xref ref-type="supplementary-material" rid="pone.0059525.s004">Table S1</xref>. The amplified DNA fragment containing each gene was ligated into <italic>Bam</italic>HI sites of pSTV29 (Takara Co.) or pUC19.</p></sec><sec id="s2d"><title>Drug Susceptibility Test</title><p>The MICs of various antimicrobial agents were determined by the microdilution method according to the recommendations of the Japanese Society of Chemotherapy (Japanese Society of Chemotherapy, 1990). Briefly, MICs were determined in Mueller&#x02013;Hinton broth (Difco) containing each compound in a twofold serial dilution series. About 10<sup>4</sup> cells were inoculated in each well of a microtiter plate, incubated in the test medium at 37&#x000b0;C for 24 h, and growth was examined visually. The MIC of each compound was defined as the lowest concentration that prevented visible growth.</p></sec><sec id="s2e"><title>Energy Starvation and Loading Fluorescent Substance</title><p>
<italic>E. coli</italic> KAM32 harboring the recombinant plasmid was grown in LB medium at 37&#x000b0;C until OD<sub>650</sub>&#x02248;0.8. Cells were harvested and washed twice with modified Tanaka buffer (pH 7.0) containing 2 mM MgSO<sub>4</sub>
<xref rid="pone.0059525-Tanaka1" ref-type="bibr">[37]</xref>. Cells were resuspended in this buffer containing acriflavine (final concentration: 4.2 &#x000b5;M) or 4', 6-diamidino-2-phenylindole (DAPI, final concentration: 5 &#x000b5;M). Then, in order to load fluorescent dye into the cells, cells were incubated at 37&#x000b0;C for 2.5 hr in the presence of 100 &#x000b5;M carbonylcyanide-<italic>m</italic>-chlorophenylhydrazone (CCCP). Control cells and <italic>pdrM</italic>-possessing cells were normalized according to cell density and fluorescent intensity. By initially adjusting the cell density of control and sample cells, the fluorescent intensity was roughly adjusted. Then the fluorescent intensity was slightly adjusted last before the assay.</p></sec><sec id="s2f"><title>Efflux of Fluorescent Substance</title><p>Efflux of acriflavine or DAPI was carried out as previously described <xref rid="pone.0059525-Chen1" ref-type="bibr">[32]</xref>, <xref rid="pone.0059525-Lee1" ref-type="bibr">[38]</xref>. Energy starved and fluorescent dye -loaded cells were washed three times with 0.1 M 3-morpholinopropanesulfonic acid (MOPS)- tetramethylammonium hydroxide (TMAH) (pH 7.0) containing 2 mM MgSO<sub>4</sub> and the appropriate concentration of fluorescent dye (4.2 &#x000b5;M acriflavine or 5 &#x000b5;M DAPI), and were resuspended in the same buffer. Fluorometric measurements were performed at 37&#x000b0;C with a Hitachi F-2000 fluorescence spectrometer. Excitation and emission wavelengths used for the acriflavine efflux assay were 468 nm and 499 nm, respectively, whilst 332 nm and 462 nm were used for the DAPI efflux assay. After preincubation at 37&#x000b0;C for 4 min, lactate-TMAH (pH 7.0) (final concentration 20 mM) was added to energize the cells, and then NaCl, LiCl, or KCl (final concentration 10 mM) was added to the assay mixture.</p></sec><sec id="s2g"><title>Acriflavine Efflux from Cells Induced by an Artificial Inward Na<sup>+</sup> Gradient</title><p>Based on our previous report, accelerated acriflavine efflux was measured by generating a transient Na<sup>+</sup> gradient <xref rid="pone.0059525-Morita2" ref-type="bibr">[30]</xref>. Energy-starved and fluorescent dye -loaded cells were washed three times with 0.1 M MOPS-TMAH (pH 7.0) containing 2 mM MgSO<sub>4</sub> and 4.2 &#x000b5;M acriflavine, and were resuspended in the same buffer. Buffer containing NaCl or KCl (final concentration 100 mM) was incubated at 37&#x000b0;C for 4 min to draw a base line. Then, prepared cells were added to the incubating buffer to make cells impose an inward Na<sup>+</sup> gradient and acriflavine fluorescence at 499 nm was monitored with excitation at 468 nm.</p></sec><sec id="s2h"><title>Efflux of Na<sup>+</sup> Induced by Addition of Acriflavine</title><p>Na<sup>+</sup> efflux by the addition of acriflavine was observed as previously described <xref rid="pone.0059525-Morita2" ref-type="bibr">[30]</xref>. Briefly, <italic>E. coli</italic> KAM32 harboring recombinant plasmids were grown in modified Tanaka medium <xref rid="pone.0059525-Tanaka1" ref-type="bibr">[37]</xref> supplemented with 1% tryptone, 5 mM MgSO<sub>4</sub>, and 10 mM melibiose at 30&#x000b0;C <xref rid="pone.0059525-Lopilato1" ref-type="bibr">[39]</xref>. Cells were harvested at the late-exponential phase of growth, and washed three times with 0.1 M MOPS-TMAH (pH 7.0) containing 5 mM MgSO<sub>4</sub>, and were resuspended in the same buffer. A portion of this suspension was diluted to approximately 9 mg protein/ml in the same buffer containing 250 &#x000b5;M NaCl.</p><p>Cells were incubated at 25&#x000b0;C in a plastic vessel with rapid stirring, and N<sub>2</sub> gas was blown continuously to maintain anaerobic conditions. A Na<sup>+</sup>-electrode (Radiometer, Copenhagen, Denmark) and reference electrode were put into the vessel <xref rid="pone.0059525-Tsuchiya1" ref-type="bibr">[40]</xref>. Methyl-&#x003b2;-D-galactopyranoside (M&#x003b2;gal), a substrate of the melibiose transporter, which is coupled to Na<sup>+</sup> efflux <xref rid="pone.0059525-Tsuchiya2" ref-type="bibr">[41]</xref>, was added (final concentration of 5 mM) to induce Na<sup>+</sup> uptake into cells. Thereafter, acriflavine was added to the assay mixture (final concentration, 200 &#x000b5;M). Changes in the Na<sup>+</sup> concentration of the assay medium were monitored with a Na<sup>+</sup> electrode. Calibration was carried out by the addition of known amounts of NaCl.</p></sec><sec id="s2i"><title>Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis</title><p>Total RNA was extracted using the QIAGEN RNeasy Mini Kit (QIAGEN Inc.) from <italic>S. pneumoniae</italic> R6 cultures grown in BHI broth until the exponential phase. For efficient RNA extraction, cells were broken well with a QIA shredder (QIAGEN Inc.) prior to RNA extraction. The extracted total RNA was applied to RT-PCR with the QIAGEN One-Step RT-PCR Kit (QIAGEN Inc.). Primers used for RT-PCR are listed in <xref ref-type="supplementary-material" rid="pone.0059525.s004">Table S1</xref>. PCR without the reverse-transcriptase reaction was performed to confirm no detectable DNA contamination. RT-PCR products were analyzed by 3% Agarose X (Nippon Gene Co.) gel electrophoresis.</p></sec><sec id="s2j"><title>Gene Disruption in <italic>Bacillus subtilis</italic>
</title><p>
<italic>Bacillus subtilis</italic> 168, RIK356, RIK482, and RIK483 were kind gifts from Prof. Kawamura in Rikkyo University, College of Science. <italic>B. subtilis</italic> strains were cultured aerobically in LB broth at 37&#x000b0;C. A GMM agar plate (0.6% KH<sub>2</sub>PO<sub>4</sub>, 1.4% K<sub>2</sub>HPO<sub>4</sub>, 0.2% (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1% Na citrate 2 H<sub>2</sub>O, 0.5% glucose, 0.02% MgSO<sub>4</sub>, 1.5% agar) was used to select a strain using the auxotrophic phenotype <xref rid="pone.0059525-Spizizen1" ref-type="bibr">[42]</xref>. The following concentrations of antibiotics were added when needed: kanamycin (final concentration 5 &#x000b5;g/ml), erythromycin (final concentration 0.5 &#x000b5;g/ml), chloramphenicol (final concentration 10 &#x000b5;g/ml), and tetracycline (final concentration 10 &#x000b5;g/ml). Gene disruption on <italic>B. subtilis</italic> was performed according to the method by Ochi et al <xref rid="pone.0059525-Ochi1" ref-type="bibr">[43]</xref>. Primers used for gene disruption were shown in <xref ref-type="supplementary-material" rid="pone.0059525.s004">Table S1</xref>.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Functional Cloning of <italic>pdrM</italic>
</title><p>We cloned genes relating to drug resistance from <italic>S. pneumoniae</italic> R6 <xref rid="pone.0059525-Hoskins1" ref-type="bibr">[44]</xref> using a shot-gun method, and isolated eight hybrid plasmids that conferred acriflavine resistance to the heterologous host, <italic>E. coli</italic> KAM32. <italic>E. coli</italic> cells possessing hybrid plasmids showed resistance not only to acriflavine but also to norfloxacin, suggesting that the cloned gene is related to multidrug resistance. All hybrid plasmids possessed a common region of approximately 3 kbp, and we chose one of the eight plasmids, pHAP5, for the following analysis (<xref ref-type="supplementary-material" rid="pone.0059525.s001">Figure S1</xref>).</p></sec><sec id="s3b"><title>Sequence Analysis of pHAP5</title><p>We identified the DNA region cloned in pHAP5 by comparing the partially determined sequence of pHAP5 with the <italic>S. pneumoniae</italic> R6 genome sequence (<ext-link ext-link-type="uri" xlink:href="http://www.streppneumoniae.com/">http://www.streppneumoniae.com/</ext-link>). The cloned region on pHAP5 contained one intact ORF (spr1052) and parts of two additional ORFs (spr1051 and spr1053).</p><p>spr1053 was deduced to encode dihydroorotase <xref rid="pone.0059525-Turnbough1" ref-type="bibr">[45]</xref>, an enzyme in the ribonucleotide biosynthetic pathway, whilst spr1051 was deduced to encode an AcoA homolog. AcoA was reported to be an alpha chain of thiamine-PPi dependent acetoin dehydrogenase in <italic>B. subtilis</italic>
<xref rid="pone.0059525-Huang1" ref-type="bibr">[46]</xref>.</p><p>spr1052 encodes a protein similar to NorM from <italic>V. parahaemolyticus</italic> (ACCESSION No. AB010463.1), YdhE from <italic>E. coli</italic> (ACCESSION No. U00096.2), and AbeM from <italic>Acinetobacter baumannii</italic> (ACCESSION No. AB204810.2). These proteins belong to the MATE-type multidrug efflux pump (<xref ref-type="table" rid="pone-0059525-t001">Table 1</xref>, <xref ref-type="supplementary-material" rid="pone.0059525.s002">Figure S2</xref>), leading us to predict that spr1052 also encodes a MATE-type multidrug efflux pump <xref rid="pone.0059525-Kuroda1" ref-type="bibr">[28]</xref>, <xref rid="pone.0059525-Omote1" ref-type="bibr">[47]</xref>. We named this gene <italic>pdrM</italic> (<underline>P</underline>neumococcal <underline>D</underline>rug <underline>R</underline>esistance).</p><table-wrap id="pone-0059525-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.t001</object-id><label>Table 1</label><caption><title>Similarity of putative MATE transporters in <italic>S. pneumoniae</italic> R6 with characterized MATE-type transporters.</title></caption><alternatives><graphic id="pone-0059525-t001-1" xlink:href="pone.0059525.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">spr1052 (PdrM)</td><td align="left" rowspan="1" colspan="1">spr1756</td><td align="left" rowspan="1" colspan="1">spr1877</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Cluster 1</bold>
<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>spr1756 (</bold>
<bold><italic>Sp</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">59</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>spr1877 (</bold>
<bold><italic>Sp</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>AbeM (</bold>
<bold><italic>Ab</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>NorM (</bold>
<bold><italic>Vp</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">49</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>HmrM (</bold>
<bold><italic>Hi</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">63</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>VcmA (</bold>
<bold><italic>Vc</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Cluster 2</bold>
<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>ALF5 (</bold>
<bold><italic>At</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>ERC1 (</bold>
<bold><italic>Sc</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>hMATE1 (</bold>
<bold><italic>Hs</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>TT12 (</bold>
<bold><italic>At</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Cluster 3</bold>
<xref ref-type="table-fn" rid="nt101">*</xref>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>DinF (</bold>
<bold><italic>Ec</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>VmrA (</bold>
<bold><italic>Vp</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">41</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>MepA (</bold>
<bold><italic>Sa</italic></bold>
<bold>)</bold>
</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">62</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>*</label><p>The classification was referred to the result of analysis with ClustalW and reference <xref rid="pone.0059525-Omote1" ref-type="bibr">[47]</xref>.</p></fn><fn id="nt102"><label/><p>Genetyx ver. 7.0.8 was used to estimate the scores of identity and similarity.</p></fn><fn id="nt103"><label/><p>
<italic>Sp : Streptococcus pneumoniae, Ab : Acinetobacter baumannii, Hi : Haemophilus influenzae, Vc : Vibrio cholerae, At : Arabidopsis thaliana, Sc : Saccharomyces cerevisiae, Hs : Homo sapiens, Ec : Escherichia coli, Vp : Vibrio parahaemolyticus, Sa : Staphylococcus aureus.</italic>
</p></fn></table-wrap-foot></table-wrap><p>The <italic>pdrM</italic> ORF was estimated to be 1,359 bp and was presumed to encode a hydrophobic protein of 453 amino acid residues. A terminator-like sequence was found downstream of spr1053 (upstream of <italic>pdrM</italic>) and a promoter-like sequence was found upstream of <italic>pdrM</italic> (Software: Genetyx Version 7.0.8). No promoter or promoter-like sequence was identified around the <italic>Bam</italic>HI cloning site on the pHY300PLK cloning vector. Thus, spr1053 and <italic>pdrM</italic> do not appear to be operonic and <italic>pdrM</italic> cloned on pHY300PLK is presumed to be expressed from its own promoter in <italic>E. coli</italic> cells. A terminator-like sequence was found downstream of <italic>pdrM</italic>, and a promoter-like sequence was found upstream of spr1051. For these reasons, <italic>pdrM</italic> appears to be a monocistronic gene.</p></sec><sec id="s3c"><title>Drug Susceptibility Testing</title><p>The MIC of various antibiotics was measured in <italic>E. coli</italic> KAM32 transformed with the <italic>pdrM</italic>-expressing plasmid (<xref ref-type="table" rid="pone-0059525-t002">Table 2</xref>). The MIC of acriflavine in KAM32/pHAP5 was four times higher than that of KAM32/pHY300PLK. The MICs of norfloxacin and DAPI in KAM32/pHAP5 also increased four and sixteen times, respectively, demonstrating that <italic>pdrM</italic> is indeed a gene involved in multidrug resistance.</p><table-wrap id="pone-0059525-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.t002</object-id><label>Table 2</label><caption><title>Drug susceptibility in cells transformed with <italic>pdrM.</italic>
</title></caption><alternatives><graphic id="pone-0059525-t002-2" xlink:href="pone.0059525.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="7" align="left" rowspan="1">MIC (&#x000b5;g/ml)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">
<italic>E. coli</italic> KAM32</td><td colspan="3" align="left" rowspan="1">
<italic>B. subtilis</italic> TN26</td><td align="left" rowspan="1" colspan="1">
<italic>B. subtilis</italic> 168</td></tr><tr><td align="left" rowspan="1" colspan="1">Antimicrobial agents</td><td align="left" rowspan="1" colspan="1">pHY300PLK (control)</td><td colspan="2" align="left" rowspan="1">pHAP5 (<italic>pdrM</italic>)</td><td align="left" rowspan="1" colspan="1">pHY300PLK (control)</td><td align="left" rowspan="1" colspan="1">pHAP5 (<italic>pdrM</italic>)</td><td align="left" rowspan="1" colspan="1">(parental strain)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Norfloxacin</td><td align="left" rowspan="1" colspan="1">0.015</td><td colspan="2" align="left" rowspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Ciprofloxacin</td><td align="left" rowspan="1" colspan="1">0.004</td><td colspan="2" align="left" rowspan="1">0.008</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.125</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Enoxacin</td><td align="left" rowspan="1" colspan="1">0.06</td><td colspan="2" align="left" rowspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Ofloxacin</td><td align="left" rowspan="1" colspan="1">0.015</td><td colspan="2" align="left" rowspan="1">0.015</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Chloramphenicol</td><td align="left" rowspan="1" colspan="1">0.25</td><td colspan="2" align="left" rowspan="1">0.5</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Erythromycin</td><td align="left" rowspan="1" colspan="1">2</td><td colspan="2" align="left" rowspan="1">4</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Acriflavine</td><td align="left" rowspan="1" colspan="1">2</td><td colspan="2" align="left" rowspan="1">8</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>DAPI</td><td align="left" rowspan="1" colspan="1">0.125</td><td colspan="2" align="left" rowspan="1">2</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>EtBr</td><td align="left" rowspan="1" colspan="1">4</td><td colspan="2" align="left" rowspan="1">4</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Benzalkonium Cl</td><td align="left" rowspan="1" colspan="1">4</td><td colspan="2" align="left" rowspan="1">4</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Rhodamine 6G</td><td align="left" rowspan="1" colspan="1">8</td><td colspan="2" align="left" rowspan="1">8</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>TPPCl</td><td align="left" rowspan="1" colspan="1">4</td><td colspan="2" align="left" rowspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">64</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>DAPI: 4&#x02032;,6-diamidino-2-phenylindole, EtBr: ethidium bromide,</p></fn><fn id="nt105"><label/><p>TPPCl: tetraphenylphosphonium chloride, ND: not determined.</p></fn></table-wrap-foot></table-wrap><p>We suspected that PdrM may be more active in Gram positive bacteria than in <italic>E. coli</italic> because <italic>S. pneumoniae</italic> is a Gram positive bacterium. <italic>B. subtilis</italic> is one of the legally recognized hosts of genetic transformation in Japan, and we planned to investigate the activity of PdrM in <italic>B. subtilis</italic>. However, we knew that the basic drug resistant levels of wild type strains often prevented detection of the activity of a drug efflux pump, and we constructed <italic>B. subtilis</italic> TN26 from <italic>B. subtilis</italic> 168 before the investigations. Six genes (<italic>bmr</italic>
<xref rid="pone.0059525-Neyfakh1" ref-type="bibr">[48]</xref>, <italic>ebrAB</italic>
<xref rid="pone.0059525-Masaoka1" ref-type="bibr">[49]</xref>, <italic>blt</italic>
<xref rid="pone.0059525-Ahmed1" ref-type="bibr">[50]</xref>, <italic>bmrA</italic>
<xref rid="pone.0059525-Steinfels1" ref-type="bibr">[51]</xref>, <italic>yerP</italic>
<xref rid="pone.0059525-Tsuge1" ref-type="bibr">[52]</xref>, and <italic>bmr3</italic>
<xref rid="pone.0059525-Ohki1" ref-type="bibr">[53]</xref>) for the drug efflux pump were disrupted in <italic>B. subtilis</italic> TN26. The MIC of tetraphenylphosphonium chloride in <italic>B. subtilis</italic> TN26 was sixteen times lower than that of the parental strain 168 and the MICs of norfloxacin, acriflavine, and ethidium bromide were also four times lower than that of the parental strain (<xref ref-type="table" rid="pone-0059525-t002">Table 2</xref>). We then measured the drug resistant level in <italic>B. subtilis</italic> TN26 transformed with <italic>pdrM</italic>. However, <italic>pdrM</italic> was unable to elevate the MIC of the chemicals we investigated although the host was the same Gram positive bacterium <italic>B. subtilis</italic> as <italic>S. pneumoniae</italic>. We considered that the slightly decreased MIC of ciprofloxacin were in a range for error. We confirmed the mRNA expression of <italic>pdrM</italic> in <italic>B. subtilis</italic> TN26/pHAP5 using RT-PCR (<xref ref-type="supplementary-material" rid="pone.0059525.s003">Figure S3</xref>), and there may be some difficulty with translation or transition to the membrane in <italic>B. subtilis</italic>. As another reason, it may be possible that the basic resistant levels for quinolones and DAPI are still too high in <italic>B. subtilis</italic> TN26 to detect MIC changes.</p></sec><sec id="s3d"><title>Drug Efflux Assay</title><p>PdrM recognized DAPI and acriflavine as its good substrates. Therefore, we investigated the efflux activity of DAPI and acriflavine in <italic>E. coli</italic> KAM32/pHAP5 (<xref ref-type="fig" rid="pone-0059525-g001">Figure 1</xref>). No active efflux activity was observed when only lactate was added to the cell suspension. Consequently, NaCl was added to the assay mixture, and significant DAPI efflux was observed. The addition of LiCl also activated DAPI efflux as strongly as NaCl, although the efflux of DAPI was not observed when KCl was added to the assay mixture. Thus, Na<sup>+</sup> and Li<sup>+</sup> cations, but not Cl<sup>-</sup>, facilitate the efflux activity of PdrM. A similar result was observed when acriflavine was used as the substrate for the efflux assay (data not shown).</p><fig id="pone-0059525-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g001</object-id><label>Figure 1</label><caption><title>Effect of monovalent cations on energy-dependent DAPI efflux mediated by PdrM.</title><p>Lactate-TMAH (final concentration 20 mM, pH 7.0) was added to the assay mixture (at the first arrow). At the time point indicated by the second arrow, either NaCl (curve a), LiCl (curve b), or KCl (curve c) was added to the assay mixture (final concentration 10 mM). (A) <italic>E. coli</italic> KAM32/pHAP5, (B) <italic>E. coli</italic> KAM32/pHY300PLK (control). The fluorescence of free DAPI and DAPI binding with DNA was detected in the DAPI assay. However, the fluorescence from DAPI binding with DNA was stronger than free DAPI and the fluorescent intensity decreased when DAPI was pumped out of the cells.</p></caption><graphic xlink:href="pone.0059525.g001"/></fig><p>Next, we investigated the dependency of DAPI efflux on NaCl concentrations (<xref ref-type="fig" rid="pone-0059525-g002">Figure 2(A)</xref>). DAPI efflux in <italic>E. coli</italic> KAM32/pHAP5 was accelerated with increasing NaCl concentrations, and reached a plateau at 100 mM NaCl. DAPI efflux was also stimulated in a concentration-dependent manner by LiCl (data not shown). DAPI efflux curves almost coincided when the same concentration of LiCl was added (data not shown). Thus, NaCl and LiCl are compatible with one another in DAPI efflux.</p><fig id="pone-0059525-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g002</object-id><label>Figure 2</label><caption><title>Salt concentration-dependent fluorescent dye efflux via PdrM.</title><p>DAPI efflux activity (A). The concentration of NaCl or LiCl is (a) 0 mM, (b) 1 mM, (c) 10 mM, (d) 30 mM, (e) 50 mM, (f) 80 mM, and (g) 100 mM. Acriflavine efflux activity (B). The concentration of NaCl or LiCl is (a) 0 &#x000b5;M, (b) 10 &#x000b5;M, (c) 100 &#x000b5;M, (d) 1 mM, (e) 10 mM, and (f) 20 mM. Acriflavine fluorescence was quenched in cells because of its concentration. When an energy source was added, acriflavine was expelled and acriflavine fluorescence increased. Different from DAPI, the fluorescence of acriflavine does not change by DNA binding.</p></caption><graphic xlink:href="pone.0059525.g002"/></fig><p>It was also observed that acriflavine was effluxed in a Na<sup>+</sup> concentration-dependent manner (<xref ref-type="fig" rid="pone-0059525-g002">Figure 2(B)</xref>). Incongruously, however, DAPI efflux was maximal at &#x0223c;100 mM Na<sup>+</sup> whereas maximal acriflavine efflux occurred at &#x0223c;10 mM Na<sup>+</sup>. Various reasons were conceived to explain this discrepancy. However, the most possible reason we could think of was that the lowest concentrations of DAPI and acriflavine detectable by our luminometric method may be different. Alternatively, stoichiometry with Na<sup>+</sup> may be different between DAPI and acriflavine.</p></sec><sec id="s3e"><title>Na<sup>+</sup> Efflux Elicited by Acriflavine Influx</title><p>Several reported MATE-type multidrug efflux pumps are known to utilize Na<sup>+</sup> to extrude their substrates <xref rid="pone.0059525-Morita2" ref-type="bibr">[30]</xref>, <xref rid="pone.0059525-Huda1" ref-type="bibr">[31]</xref>, <xref rid="pone.0059525-Chen1" ref-type="bibr">[32]</xref>, <xref rid="pone.0059525-Huda2" ref-type="bibr">[33]</xref>, <xref rid="pone.0059525-Xu1" ref-type="bibr">[34]</xref>, <xref rid="pone.0059525-Long1" ref-type="bibr">[35]</xref>. Therefore, we investigated whether Na<sup>+</sup> movement accompanied substrate extrusion via PdrM (<xref ref-type="fig" rid="pone-0059525-g003">Figure 3</xref>). Indeed, Na<sup>+</sup> was extruded when acriflavine was added to a cell suspension of <italic>E. coli</italic> expressing <italic>pdrM</italic>. This result demonstrates that PdrM acts as an antiporter to exchange Na<sup>+</sup> and acriflavine, and that Na<sup>+</sup> is utilized as a coupling cation to transport drugs.</p><fig id="pone-0059525-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g003</object-id><label>Figure 3</label><caption><title>Na<sup>+</sup> efflux from Na<sup>+</sup>-loaded cells elicited by an inwardly directed acriflavine gradient.</title><p>Cells of <italic>E. coli</italic> KAM32/pHAP5 or <italic>E. coli</italic> KAM32/pHY300PLK (control) were diluted with 0.1 M MOPS-TMAH (pH7.0) until approximately 9 mg protein/ml. Na<sup>+</sup> was loaded to cells via MelB by the addition of M&#x003b2;gal (the first arrow), and acriflavine (final 200 &#x000b5;M) was added to the assay mixture at the time point indicated by the second arrow. Upward deflection of the curve indicates Na<sup>+</sup> influx into cells and downward deflection indicates Na<sup>+</sup> efflux from cells.</p></caption><graphic xlink:href="pone.0059525.g003"/></fig><p>Acriflavine should be expelled in the presence of an artificial Na<sup>+</sup> concentration gradient if PdrM antiports Na<sup>+</sup> and acriflavine. To investigate this, acriflavine efflux via PdrM was measured in cells with a reduced intracellular Na<sup>+</sup> concentration. Energy-starved and acriflavine-loaded cells, in which Na<sup>+</sup> concentrations are low, were prepared. Then, the cells were rapidly added to the assay mixture containing NaCl (final concentration 100 mM) to form an inward Na<sup>+</sup> gradient. As a result, acriflavine was effluxed from <italic>pdrM</italic>-possessing cells in response to the Na<sup>+</sup> gradient (<xref ref-type="fig" rid="pone-0059525-g004">Figure 4</xref>).</p><fig id="pone-0059525-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g004</object-id><label>Figure 4</label><caption><title>Acriflavine efflux from cells elicited by an inwardly directed artificial Na<sup>+</sup> gradient.</title><p>An inwardly directed chemical gradient of Na<sup>+</sup> was imposed by the addition of the cell suspension into the assay medium containing salt at the time point indicated by the arrow. (A) <italic>E. coli</italic> KAM32/pHAP5, (B) <italic>E. coli</italic> KAM32/pHY300PLK. The final concentration of the salt was 100 mM NaCl (curve a) or 100 mM KCl (curve b). The assay was performed at 37&#x000b0;C.</p></caption><graphic xlink:href="pone.0059525.g004"/></fig><p>In contrast, this phenomenon was not observed with KCl instead of NaCl. This result also shows that acriflavine efflux is dependent on Na<sup>+</sup> and is not due to the effect of osmotic pressure or Cl<sup>&#x02212;</sup>.</p><p>We also investigated the antiport activity of norfloxacin and H<sup>+</sup> via PdrM using a quinacrine fluorescence method <xref rid="pone.0059525-Kuroda2" ref-type="bibr">[54]</xref>, but the movement of H<sup>+</sup> was not induced by the addition of norfloxacin or DAPI (<xref ref-type="fig" rid="pone-0059525-g005">Figure 5</xref>).</p><fig id="pone-0059525-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g005</object-id><label>Figure 5</label><caption><title>H<sup>+</sup> efflux assay in the inverted vesicle.</title><p>H<sup>+</sup> efflux activity was tested with inverted membrane vesicles from <italic>E. coli</italic> KAM32/pHAP5 (solid line) and KAM32/pHY300PLK (dashed line). Each reagent was added at the time point shown by the arrow. The final concentration of lactate, potassium salt was 5 mM. Potassium lactate adjusted at pH 7.0 was used for the assay. The final concentrations of DAPI and NFLX were 5 &#x000b5;M and 250 &#x000b5;M, respectively, and the final concentration of triton X100 was 0.0125%. The assay mixture is 0.1 M Tricine-KOH (pH 8.0) containing 5 mM MgSO<sub>4</sub> (panel A). 0.1 M MOPS-KOH containing 5 mM MgSO<sub>4</sub> was used for the assay at pH 6.5 (Panel B) and pH 7.0 (data not shown). The result at pH 7.0 was similar to panel A. An assay with NFLX at pH 8.0 was also performed, but H<sup>+</sup> efflux activity was not observed.</p></caption><graphic xlink:href="pone.0059525.g005"/></fig></sec><sec id="s3f"><title>Putative MATE Efflux Pumps in <italic>S. pneumonaie</italic> R6</title><p>We found three genes &#x02013; spr1756, spr1877, and <italic>pdrM</italic> &#x02013; that met the criteria of the MATE family by searching the <italic>S. pneumoniae</italic> genome database (<xref ref-type="supplementary-material" rid="pone.0059525.s002">Figure S2</xref>). Of these three genes, spr1756 was reported to encode a protein whose function is similar to DinF <xref rid="pone.0059525-MortierBarriere1" ref-type="bibr">[55]</xref>. Recently, Tocci et al reported three ORFs (SP1166, SP1939, and SP2065) belonging to MATE in <italic>S. pneumoniae</italic> DP1004 <xref rid="pone.0059525-Tocci1" ref-type="bibr">[56]</xref>. From the putative amino acid sequence, SP1166, SP1939, and SP2065 in <italic>S. pneumoniae</italic> DP1004 are thought to encode the orthologs of <italic>pdrM</italic>, spr1756, and spr1877 in <italic>S. pneumoniae</italic> R6, respectively. We cloned spr1756, spr1877, and <italic>pdrM</italic> by PCR, and measured the MIC of several antibiotics in <italic>E. coli</italic> KAM32 expressing the cloned gene (<xref ref-type="table" rid="pone-0059525-t003">Table 3</xref>). Expression of <italic>pdrM</italic> cloned by PCR also led to elevated resistance against acriflavine and DAPI to the same extent as the <italic>pdrM</italic> cloned functionally (described above). spr1756 and spr1877 did not elevate the MIC of any of the drugs. mRNA of all three genes, however, were detected in <italic>S. pneumoniae</italic> R6 under laboratory growth conditions (<xref ref-type="fig" rid="pone-0059525-g006">Figure 6</xref>). Tocci et al constructed a spr1756-disrupted mutant from <italic>S. pneumoniae</italic> R6 and revealed that the MICs of moxifloxacin and levofloxacin were slightly lower in the mutant. Spr1756 may be able to efflux moxifloxacin; however, we speculate that the main role of spr1756 may be different from expelling antimicrobial chemicals in <italic>S. pneumoniae</italic> R6. spr1877 is also expected to have a physiological role that is presumably unrelated to drug resistance.</p><fig id="pone-0059525-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.g006</object-id><label>Figure 6</label><caption><title>RT-PCR analysis in <italic>S. pneumoniae</italic> R6.</title><p>One ng total RNA was used for the template for one reaction of RT-PCR, and the reaction was repeated for 24 cycles. pUC19 digested with <italic>Msp</italic> I was used as a size marker (lane M). <italic>pdrM</italic> (lane a, e), spr1756 (lane b, f), spr1877 (lane c, g). The expression of the <italic>atpB</italic> was used as an internal control (lane d, h). Reverse transcriptional reactions were submitted on samples in lane a, b, c, and d, and were not on samples in lane e, f, g, and h.</p></caption><graphic xlink:href="pone.0059525.g006"/></fig><table-wrap id="pone-0059525-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0059525.t003</object-id><label>Table 3</label><caption><title>Drug susceptibility in cells transformed with genes predicted from genome information.</title></caption><alternatives><graphic id="pone-0059525-t003-3" xlink:href="pone.0059525.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="5" align="left" rowspan="1">MIC (&#x000b5;g/ml)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="left" rowspan="1">host : <italic>E. coli</italic> KAM32</td></tr><tr><td align="left" rowspan="1" colspan="1">Antimicrobial agents</td><td align="left" rowspan="1" colspan="1">pSTV29 (control)</td><td align="left" rowspan="1" colspan="1">
<italic>pdrM</italic> (spr1052)</td><td align="left" rowspan="1" colspan="1">spr1756</td><td align="left" rowspan="1" colspan="1">spr1877</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Oxacillin</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Cloxacillin</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Erythromycin</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Norfloxacin</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Acriflavine</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Hoechst 33342</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>DAPI</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Methyl viologen</td><td align="left" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">128</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Novobiocin</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Trimethoprim</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x02003;</bold>Safranin O</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt106"><label/><p>DAPI: 4&#x02032;,6-diamidino-2-phenylindole.</p></fn></table-wrap-foot></table-wrap><p>MATE-type pumps are phylogenetically classified into three clusters. PdrM is categorized into cluster 1 <xref rid="pone.0059525-Brown1" ref-type="bibr">[57]</xref>, along with typical bacterial MATE-type efflux pumps such as NorM from <italic>V. parahaemolyticus</italic> and YdhE from <italic>E. coli</italic> (<xref ref-type="supplementary-material" rid="pone.0059525.s002">Figure S2</xref>). In contrast, spr1756 and spr1877 are classified into cluster 3 <xref rid="pone.0059525-Brown1" ref-type="bibr">[57]</xref>. Bioinformatic analysis predicted that many bacterial membrane proteins belong to cluster 3, but only a few of them, (<italic>e. g.</italic> MepA from <italic>S. aureus</italic>
<xref rid="pone.0059525-McAleese1" ref-type="bibr">[58]</xref>, VmrA from <italic>V. parahaemolyticus</italic>
<xref rid="pone.0059525-Chen1" ref-type="bibr">[32]</xref>, and DinF from <italic>Ralstonia solanacearum</italic>
<xref rid="pone.0059525-Brown2" ref-type="bibr">[59]</xref>) were actually shown to possess the drug efflux activity. Indeed, DinF from <italic>E. coli</italic> is a well-known protein that belongs to cluster 3 in the MATE family but has not been reported to contribute to drug resistance. Proteins in cluster 3 may be rarely involved in drug resistance in bacteria.</p><p>What are the roles of spr1756 and spr1877? They are expressed under laboratory conditions, and we suggested that they have some as of yet undetermined role under these culture conditions. Mu&#x000f1;oz-El&#x000ed;as&#x02019;s group isolated a mutant possessing a transposon in spr1756 (<italic>dinF</italic>), corresponding to sp1939 in <italic>S. pneumoniae</italic> TIGR4 <xref rid="pone.0059525-MunozElias1" ref-type="bibr">[60]</xref>, and the transposon mutant in sp1939 formed poorer biofilms than the parent, <italic>S. pneumoniae</italic> TIGR4. Their results may support our hypothesis that spr1756 and spr1877 gene products play some role unrelated to drug resistance in <italic>S. pneumoniae,</italic> although a specific physiological role of spr1756 is still unknown.</p></sec></sec><sec id="s4"><title>Discussion</title><p>We cloned a MATE-type multidrug efflux pump gene, <italic>pdrM</italic> from <italic>S. pneumoniae</italic> R6. PdrM effluxes acriflavine and DAPI in a Na<sup>+</sup> dependent manner. We could not detect the antiport activity of norfloxacin (or DAPI) and H<sup>+</sup> via PdrM though we previously found AbeM from <italic>A. baumannii</italic>, which is a H<sup>+</sup>-coupled MATE-type efflux pump <xref rid="pone.0059525-Su1" ref-type="bibr">[61]</xref>. Therefore, we considered H<sup>+</sup> was unlikely to be moved via PdrM.</p><p>Sodium circulation in <italic>S. pneumoniae</italic> has not been investigated extensively. Kakinuma et al reported that Na<sup>+</sup>-ATPase classified into V-type ATPase in <italic>Enterococcus hirae</italic> was closely related to Streptococci <xref rid="pone.0059525-Murata1" ref-type="bibr">[62]</xref> and the Na<sup>+</sup>/proton antiporter in <italic>Enterococcus faecalis</italic>
<xref rid="pone.0059525-Kakinuma1" ref-type="bibr">[63]</xref>. In <italic>Streptococcus bovis</italic>, sodium-dependent transport of neutral amino acids was reported in both whole cells and membrane vesicles <xref rid="pone.0059525-Russell1" ref-type="bibr">[64]</xref>. Because these closely related bacteria possess systems coupling with Na<sup>+</sup>, we assumed that the existence of systems to utilize Na<sup>+</sup> should also be expected in <italic>S. pneumoniae.</italic> We searched the genome database of <italic>S. pneumoniae</italic> R6 to determine whether the genes encoding similar proteins to the Na<sup>+</sup>-ATPase, NtpFIKECGABDHJ from <italic>E. hirae</italic> or various known Na<sup>+</sup>/proton antiporters (<italic>e.g.</italic> NhaP from <italic>Pseudomonas aeruginosa</italic>
<xref rid="pone.0059525-Utsugi1" ref-type="bibr">[65]</xref>, NhaB from <italic>E. coli</italic>
<xref rid="pone.0059525-Pinner1" ref-type="bibr">[66]</xref>, MnhA from <italic>S. aureus</italic>
<xref rid="pone.0059525-Hiramatsu1" ref-type="bibr">[67]</xref>, and human Na<sup>+</sup>/H<sup>+</sup> antiporter, NHE-2 <xref rid="pone.0059525-Collins1" ref-type="bibr">[68]</xref>) are present or not. However, no such genes were found in the genome in <italic>S. pneumoniae</italic> R6.</p><p>We did find spr0573, described to be a sodium/hydrogen exchanger family protein Nha2, in the genome database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_003098">http://www.ncbi.nlm.nih.gov/nuccore/NC_003098</ext-link>), but spr0573 is barely similar to NhaP from <italic>P. aeruginosa</italic> (less than 40% similarity). spr0573 also showed little similarity with NhaB from <italic>E. coli</italic>, MnhA from <italic>S. aureus</italic>, human NHE-2, and other known Na<sup>+</sup>/H<sup>+</sup> antiporters. Therefore, it is doubtful whether Nha2 (spr0573) is actually a Na<sup>+</sup>/H<sup>+</sup> antiporter.</p><p>We found at least three proteins possibly using Na<sup>+</sup> as a coupling ion based on the genome information of <italic>S. pneumoniae</italic> R6. They are spr1598, spr0369, and spr0648. Among them, we could not find any reports relating to spr0648. spr1598 is presumed to encode a serine transporter because of its high similarity (90%) to SstT from <italic>E. coli</italic>
<xref rid="pone.0059525-Ogawa1" ref-type="bibr">[69]</xref>. spr0369 has been renamed <italic>dagA</italic> and it has been proposed to be a protein in the sodium/alanine symporter family. More than half of N-terminal of DagA from <italic>S. pneumoniae</italic> R6 is highly similar to DagA from the marine bacterium, <italic>Alteromonas haloplankti</italic>s <xref rid="pone.0059525-MacLeod1" ref-type="bibr">[70]</xref>.</p><p>The presence of these genes and <italic>pdrM</italic> suggests that <italic>S. pneumoniae</italic> also utilizes secondary transporters coupled with Na<sup>+</sup>. Therefore, we think that <italic>S. pneumoniae</italic> possesses machineries to form a Na<sup>+</sup> motive force although we cannot predict any possible candidate genes now.</p><p>Na<sup>+</sup> and Li<sup>+</sup> significantly promoted expulsion of the fluorescent dyes, acriflavine and DAPI via PdrM, whilst K<sup>+</sup> did not. Minimal efflux of the fluorescent dyes was observed in both KAM32/pHAP5 and control cells when KCl was added to the assay mixture, and this phenomenon was observed in NorM from <italic>V. parahaemolyticus</italic>
<xref rid="pone.0059525-Morita2" ref-type="bibr">[30]</xref>. This result suggested that <italic>E. coli</italic> KAM32 possesses a weak acriflavine efflux system that is promoted in the presence of KCl, and is independent of PdrM.</p><p>On the other hand, KAM32/pHAP5 seemed to show higher acriflavine efflux activity in <xref ref-type="fig" rid="pone-0059525-g004">Figure 4(A)</xref> than in <xref ref-type="fig" rid="pone-0059525-g004">Figure 4(B)</xref>. This may have been caused by PdrM though acriflavine efflux was not observed in <xref ref-type="fig" rid="pone-0059525-g001">Figure 1</xref> and <xref ref-type="fig" rid="pone-0059525-g002">2</xref>. Contaminated Na<sup>+</sup> in high concentration KCl solution may stimulate the activity of PdrM or K<sup>+</sup> at high concentrations may play a role similar to Na<sup>+</sup>.</p><p>In summary, <italic>pdrM</italic> from <italic>S. pneumoniae</italic> has been revealed to be a MATE-type multidrug efflux pump. We would emphasize that PdrM is the first multidrug efflux pump that shows Na<sup>+</sup>-coupling availability in Gram-positive bacteria.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0059525.s001"><label>Figure S1</label><caption><p>
<bold>Restriction map of plasmid pHAP5.</bold> Horizontal bar indicates DNA regions derived from chromosomal DNA of <italic>S. pneumoniae</italic> R6. Arrows indicate ORFs of <italic>pdrM</italic> (spr1052), spr1051, and spr1053. The vector plasmids for pHAP5 and pUAP19 are pHY300PLK and pUC19, respectively.</p><p>(TIF)</p></caption><media xlink:href="pone.0059525.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0059525.s002"><label>Figure S2</label><caption><p>
<bold>Phylogeny of MATE-type proteins in S. pneumoniae and related proteins.</bold> MATE-type proteins were aligned in CLUSTAL W (Thompson JD, Higgins DG, Gibson TJ.(1994)Nucleic Acids Res. 22(22):4673&#x02013;4680.) Accession number of each protein : NP_388962(YisQ (<italic>B. subtilis</italic>)), EHJ39019(MatE (<italic>Clostridium difficile</italic>)), AAF94694(NorM (<italic>Vibrio cholerae</italic> O1), YP_213507(BF3926 (<italic>Bacteroides fragilis</italic>), P45272 (HmrM (<italic>Haemophilus influenzae</italic>), AAC17857 (YojI (<italic>B. subtilis</italic>), BAB79260 (VcmA (<italic>V. cholerae</italic> non-O1), BAB68204 (VmrA (<italic>V. parahaemolyticus</italic>), AAH35288(SLC47A2 (<italic>Homo sapiens</italic>)), AEE79863 (TT12 (<italic>Alabidopsis thaliana</italic>)), NP_178499 (<italic>A. thaliana</italic>), AAH50592 (SLC47A1 (<italic>Homo sapiens</italic>)), NP_588077 (<italic>Schizosaccharomyces pombe</italic>), BAA31456(NorM (<italic>V. parahaemolyticus</italic>)), ZP_07363019(MepA (<italic>Stapyulococcus aureus</italic>)) AEE76777(ALF5 (<italic>A. thaliana</italic>)), DAA06723(ERC1 (<italic>Saccharomyces cerevisiae</italic>), BAD89844 (AbeM (<italic>A. baumannii</italic>)), CAK08901(RL3413 (<italic>Rhizobium leguminosarum</italic>)), YP_492187(DinF (<italic>E. coli</italic>)), CAE00499 (CdeA (<italic>C. difficile</italic>)), BAB79260 (VcmA (<italic>V. cholerae</italic> non-O1)), BAD89844 (AbeM (<italic>Acinetobacter baumannii</italic>), BAD98612 (VcmD (<italic>V. cholerae</italic> non-O1)), BAB70470(VcrM (<italic>V. cholerae</italic> non-O1)).</p><p>(TIF)</p></caption><media xlink:href="pone.0059525.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0059525.s003"><label>Figure S3</label><caption><p>
<bold>mRNA expression of </bold>
<bold><italic>pdrM</italic></bold>
<bold> in </bold>
<bold><italic>B. subtilis</italic></bold>
<bold> TN26/pHAP5.</bold> Panel A: RNA from <italic>B. subtilis</italic> TN26/pHAP5, Panel B: RNA from <italic>B. subtilis</italic> TN26/pHY300PLK Total RNA was extracted using the QIAGEN RNeasy Mini Kit (QIAGEN Inc.) from <italic>B. subtilis</italic> cultures grown in LB broth with 20 &#x000b5;g/ml tetracycline until the exponential phase. Genome-derived <italic>atpB</italic> mRNA expression in <italic>B. subtilis</italic> TN26 was used as a standard. Primers, atpB(B subtilis)F and atpB(B subtilis)R for the standard were shown in <xref ref-type="supplementary-material" rid="pone.0059525.s004">Table S1</xref>. Samples in RT(-) lanes were amplified without a reverse transcriptional reaction.</p><p>(TIF)</p></caption><media xlink:href="pone.0059525.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0059525.s004"><label>Table S1</label><caption><p>
<bold>Primers used in this study.</bold>
</p><p>(DOCX)</p></caption><media xlink:href="pone.0059525.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Professor Kawamura in Rikkyo University and Dr. Nanamiya in Ehime University for giving us the gene disruption system in <italic>B. subtilis</italic>. We thank Dr. Terry John Evans for critically reading the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0059525-Diaz1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Diaz</surname><given-names>A</given-names></name>, <name><surname>Barria</surname><given-names>P</given-names></name>, <name><surname>Niederman</surname><given-names>M</given-names></name>, <name><surname>Restrepo</surname><given-names>MI</given-names></name>, <name><surname>Dreyse</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens</article-title>. <source>Chest</source>
<volume>131</volume>: <fpage>779</fpage>&#x02013;<lpage>787</lpage>.<pub-id pub-id-type="pmid">17356093</pub-id></mixed-citation></ref><ref id="pone.0059525-Vainio1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Vainio</surname><given-names>A</given-names></name>, <name><surname>Lyytikainen</surname><given-names>O</given-names></name>, <name><surname>Sihvonen</surname><given-names>R</given-names></name>, <name><surname>Kaijalainen</surname><given-names>T</given-names></name>, <name><surname>Teirila</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>An outbreak of pneumonia associated with <italic>S. pneumoniae</italic> at a military training facility in Finland in 2006</article-title>. <source>APMIS</source>
<volume>117</volume>: <fpage>488</fpage>&#x02013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">19594488</pub-id></mixed-citation></ref><ref id="pone.0059525-Lagos1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Lagos</surname><given-names>R</given-names></name>, <name><surname>Munoz</surname><given-names>A</given-names></name>, <name><surname>San Martin</surname><given-names>O</given-names></name>, <name><surname>Maldonado</surname><given-names>A</given-names></name>, <name><surname>Hormazabal</surname><given-names>JC</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994&#x02013;2007</article-title>. <source>J Infect Dis</source>
<volume>198</volume>: <fpage>1809</fpage>&#x02013;<lpage>1817</lpage>.<pub-id pub-id-type="pmid">18959497</pub-id></mixed-citation></ref><ref id="pone.0059525-Sousa1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Sousa</surname><given-names>D</given-names></name>, <name><surname>Justo</surname><given-names>I</given-names></name>, <name><surname>Dominguez</surname><given-names>A</given-names></name>, <name><surname>Manzur</surname><given-names>A</given-names></name>, <name><surname>Izquierdo</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome</article-title>. <source>Clin Microbiol Infect</source>
<volume>10</volume> (<issue>1111/j.1469&#x02013;0691.2012.03765</issue>): <fpage>x</fpage>.</mixed-citation></ref><ref id="pone.0059525-Gentile1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Gentile</surname><given-names>A</given-names></name>, <name><surname>Bardach</surname><given-names>A</given-names></name>, <name><surname>Ciapponi</surname><given-names>A</given-names></name>, <name><surname>Garcia-Marti</surname><given-names>S</given-names></name>, <name><surname>Aruj</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis</article-title>. <source>Int J Infect Dis</source>
<volume>16</volume>: <fpage>e5</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">22056731</pub-id></mixed-citation></ref><ref id="pone.0059525-Bamba1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Bamba</surname><given-names>M</given-names></name>, <name><surname>Jozaki</surname><given-names>K</given-names></name>, <name><surname>Sugaya</surname><given-names>N</given-names></name>, <name><surname>Tamai</surname><given-names>S</given-names></name>, <name><surname>Ishihara</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan</article-title>. <source>J Infect Chemother</source>
<volume>12</volume>: <fpage>36</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">16506088</pub-id></mixed-citation></ref><ref id="pone.0059525-Tajima1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Tajima</surname><given-names>T</given-names></name>, <name><surname>Nakayama</surname><given-names>E</given-names></name>, <name><surname>Kondo</surname><given-names>Y</given-names></name>, <name><surname>Hirai</surname><given-names>F</given-names></name>, <name><surname>Ito</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children</article-title>. <source>J Infect Chemother</source>
<volume>12</volume>: <fpage>372</fpage>&#x02013;<lpage>379</lpage>.<pub-id pub-id-type="pmid">17235643</pub-id></mixed-citation></ref><ref id="pone.0059525-Yanagihara1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Yanagihara</surname><given-names>K</given-names></name>, <name><surname>Izumikawa</surname><given-names>K</given-names></name>, <name><surname>Higa</surname><given-names>F</given-names></name>, <name><surname>Tateyama</surname><given-names>M</given-names></name>, <name><surname>Tokimatsu</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant <italic>Streptococcus pneumoniae</italic> infection</article-title>. <source>Intern Med</source>
<volume>48</volume>: <fpage>527</fpage>&#x02013;<lpage>535</lpage>.<pub-id pub-id-type="pmid">19336954</pub-id></mixed-citation></ref><ref id="pone.0059525-Umeki1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Umeki</surname><given-names>K</given-names></name>, <name><surname>Tokimatsu</surname><given-names>I</given-names></name>, <name><surname>Yasuda</surname><given-names>C</given-names></name>, <name><surname>Iwata</surname><given-names>A</given-names></name>, <name><surname>Yoshioka</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia</article-title>. <source>Respirology</source>
<volume>16</volume>: <fpage>856</fpage>&#x02013;<lpage>861</lpage>.<pub-id pub-id-type="pmid">21545370</pub-id></mixed-citation></ref><ref id="pone.0059525-Mitchell1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Mitchell</surname><given-names>AM</given-names></name>, <name><surname>Mitchell</surname><given-names>TJ</given-names></name> (<year>2010</year>) <article-title>
<italic>Streptococcus pneumoniae</italic>: virulence factors and variation</article-title>. <source>Clin Microbiol Infect</source>
<volume>16</volume>: <fpage>411</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="pmid">20132250</pub-id></mixed-citation></ref><ref id="pone.0059525-Jenkins1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Jenkins</surname><given-names>SG</given-names></name>, <name><surname>Farrell</surname><given-names>DJ</given-names></name> (<year>2009</year>) <article-title>Increase in pneumococcus macrolide resistance, United States</article-title>. <source>Emerg Infect Dis</source>
<volume>15</volume>: <fpage>1260</fpage>&#x02013;<lpage>1264</lpage>.<pub-id pub-id-type="pmid">19751588</pub-id></mixed-citation></ref><ref id="pone.0059525-Rantala1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Rantala</surname><given-names>M</given-names></name>, <name><surname>Huikko</surname><given-names>S</given-names></name>, <name><surname>Huovinen</surname><given-names>P</given-names></name>, <name><surname>Jalava</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Prevalence and molecular genetics of macrolide resistance among <italic>Streptococcus pneumoniae</italic> isolates collected in Finland in 2002</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>: <fpage>4180</fpage>&#x02013;<lpage>4184</lpage>.<pub-id pub-id-type="pmid">16189096</pub-id></mixed-citation></ref><ref id="pone.0059525-Mera1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Mera</surname><given-names>RM</given-names></name>, <name><surname>Miller</surname><given-names>LA</given-names></name>, <name><surname>Daniels</surname><given-names>JJ</given-names></name>, <name><surname>Weil</surname><given-names>JG</given-names></name>, <name><surname>White</surname><given-names>AR</given-names></name> (<year>2005</year>) <article-title>Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project</article-title>. <source>Diagn Microbiol Infect Dis</source>
<volume>51</volume>: <fpage>195</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="pmid">15766606</pub-id></mixed-citation></ref><ref id="pone.0059525-Song1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Song</surname><given-names>JH</given-names></name>, <name><surname>Jung</surname><given-names>SI</given-names></name>, <name><surname>Ko</surname><given-names>KS</given-names></name>, <name><surname>Kim</surname><given-names>NY</given-names></name>, <name><surname>Son</surname><given-names>JS</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>48</volume>: <fpage>2101</fpage>&#x02013;<lpage>2107</lpage>.<pub-id pub-id-type="pmid">15155207</pub-id></mixed-citation></ref><ref id="pone.0059525-Imai1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Imai</surname><given-names>S</given-names></name>, <name><surname>Ito</surname><given-names>Y</given-names></name>, <name><surname>Ishida</surname><given-names>T</given-names></name>, <name><surname>Hirai</surname><given-names>T</given-names></name>, <name><surname>Ito</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among <italic>Streptococcus pneumoniae</italic> isolates from adult patients with community-acquired pneumonia in Japan</article-title>. <source>Clin Microbiol Infect</source>
<volume>15</volume>: <fpage>1039</fpage>&#x02013;<lpage>1045</lpage>.<pub-id pub-id-type="pmid">19694764</pub-id></mixed-citation></ref><ref id="pone.0059525-Ishida1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Ishida</surname><given-names>T</given-names></name>, <name><surname>Maniwa</surname><given-names>K</given-names></name>, <name><surname>Kagioka</surname><given-names>H</given-names></name>, <name><surname>Hirabayashi</surname><given-names>M</given-names></name>, <name><surname>Onaru</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Antimicrobial susceptibilities of <italic>Streptococcus pneumoniae</italic> isolated from adult patients with community-acquired pneumonia in Japan</article-title>. <source>Respirology</source>
<volume>13</volume>: <fpage>240</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">18339022</pub-id></mixed-citation></ref><ref id="pone.0059525-Hotomi1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Hotomi</surname><given-names>M</given-names></name>, <name><surname>Billal</surname><given-names>DS</given-names></name>, <name><surname>Kamide</surname><given-names>Y</given-names></name>, <name><surname>Kanesada</surname><given-names>K</given-names></name>, <name><surname>Uno</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan</article-title>. <source>J Clin Microbiol</source>
<volume>46</volume>: <fpage>3808</fpage>&#x02013;<lpage>3810</lpage>.<pub-id pub-id-type="pmid">18832131</pub-id></mixed-citation></ref><ref id="pone.0059525-Maekawa1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Maekawa</surname><given-names>M</given-names></name>, <name><surname>Fukuda</surname><given-names>Y</given-names></name>, <name><surname>Sugiura</surname><given-names>Y</given-names></name>, <name><surname>Kamiyama</surname><given-names>T</given-names></name>, <name><surname>Futakuchi</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]</article-title>. <source>Jpn J Antibiot</source>
<volume>56</volume>: <fpage>27</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">12723396</pub-id></mixed-citation></ref><ref id="pone.0059525-Piddock1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Piddock</surname><given-names>LJ</given-names></name>, <name><surname>White</surname><given-names>DG</given-names></name>, <name><surname>Gensberg</surname><given-names>K</given-names></name>, <name><surname>Pumbwe</surname><given-names>L</given-names></name>, <name><surname>Griggs</surname><given-names>DJ</given-names></name> (<year>2000</year>) <article-title>Evidence for an efflux pump mediating multiple antibiotic resistance in <italic>Salmonella enterica</italic> serovar Typhimurium</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>44</volume>: <fpage>3118</fpage>&#x02013;<lpage>3121</lpage>.<pub-id pub-id-type="pmid">11036033</pub-id></mixed-citation></ref><ref id="pone.0059525-Sulavik1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Sulavik</surname><given-names>MC</given-names></name>, <name><surname>Houseweart</surname><given-names>C</given-names></name>, <name><surname>Cramer</surname><given-names>C</given-names></name>, <name><surname>Jiwani</surname><given-names>N</given-names></name>, <name><surname>Murgolo</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Antibiotic susceptibility profiles of <italic>Escherichia coli</italic> strains lacking multidrug efflux pump genes</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>45</volume>: <fpage>1126</fpage>&#x02013;<lpage>1136</lpage>.<pub-id pub-id-type="pmid">11257026</pub-id></mixed-citation></ref><ref id="pone.0059525-Hsieh1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Hsieh</surname><given-names>PC</given-names></name>, <name><surname>Siegel</surname><given-names>SA</given-names></name>, <name><surname>Rogers</surname><given-names>B</given-names></name>, <name><surname>Davis</surname><given-names>D</given-names></name>, <name><surname>Lewis</surname><given-names>K</given-names></name> (<year>1998</year>) <article-title>Bacteria lacking a multidrug pump: a sensitive tool for drug discovery</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>95</volume>: <fpage>6602</fpage>&#x02013;<lpage>6606</lpage>.<pub-id pub-id-type="pmid">9618458</pub-id></mixed-citation></ref><ref id="pone.0059525-Morita1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Komori</surname><given-names>Y</given-names></name>, <name><surname>Mima</surname><given-names>T</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from <italic>Pseudomonas aeruginosa</italic> PAO1: MexCD-OprJ is an inducible pump</article-title>. <source>FEMS Microbiol Lett</source>
<volume>202</volume>: <fpage>139</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">11506922</pub-id></mixed-citation></ref><ref id="pone.0059525-Gill1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Gill</surname><given-names>MJ</given-names></name>, <name><surname>Brenwald</surname><given-names>NP</given-names></name>, <name><surname>Wise</surname><given-names>R</given-names></name> (<year>1999</year>) <article-title>Identification of an efflux pump gene, <italic>pmrA</italic>, associated with fluoroquinolone resistance in <italic>Streptococcus pneumoniae</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>43</volume>: <fpage>187</fpage>&#x02013;<lpage>189</lpage>.<pub-id pub-id-type="pmid">9869592</pub-id></mixed-citation></ref><ref id="pone.0059525-TaitKamradt1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Tait-Kamradt</surname><given-names>A</given-names></name>, <name><surname>Clancy</surname><given-names>J</given-names></name>, <name><surname>Cronan</surname><given-names>M</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>F</given-names></name>, <name><surname>Wondrack</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>
<italic>mefE</italic> is necessary for the erythromycin-resistant M phenotype in <italic>Streptococcus pneumoniae</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>41</volume>: <fpage>2251</fpage>&#x02013;<lpage>2255</lpage>.<pub-id pub-id-type="pmid">9333056</pub-id></mixed-citation></ref><ref id="pone.0059525-Marrer1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Marrer</surname><given-names>E</given-names></name>, <name><surname>Schad</surname><given-names>K</given-names></name>, <name><surname>Satoh</surname><given-names>AT</given-names></name>, <name><surname>Page</surname><given-names>MG</given-names></name>, <name><surname>Johnson</surname><given-names>MM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of <italic>Streptococcus pneumoniae</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>50</volume>: <fpage>685</fpage>&#x02013;<lpage>693</lpage>.<pub-id pub-id-type="pmid">16436727</pub-id></mixed-citation></ref><ref id="pone.0059525-Saier1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name>, <name><surname>Paulsen</surname><given-names>IT</given-names></name> (<year>2001</year>) <article-title>Phylogeny of multidrug transporters</article-title>. <source>Semin Cell Dev Biol</source>
<volume>12</volume>: <fpage>205</fpage>&#x02013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">11428913</pub-id></mixed-citation></ref><ref id="pone.0059525-Boncoeur1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Boncoeur</surname><given-names>E</given-names></name>, <name><surname>Durmort</surname><given-names>C</given-names></name>, <name><surname>Bernay</surname><given-names>B</given-names></name>, <name><surname>Ebel</surname><given-names>C</given-names></name>, <name><surname>Di Guilmi</surname><given-names>AM</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>PatA and PatB form a functional heterodimeric ABC multidrug efflux transporter responsible for the resistance of <italic>Streptococcus pneumoniae</italic> to fluoroquinolones</article-title>. <source>Biochemistry</source>
<volume>51</volume>: <fpage>7755</fpage>&#x02013;<lpage>7765</lpage>.<pub-id pub-id-type="pmid">22950454</pub-id></mixed-citation></ref><ref id="pone.0059525-Kuroda1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>Multidrug efflux transporters in the MATE family</article-title>. <source>Biochim Biophys Acta</source>
<volume>1794</volume>: <fpage>763</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">19100867</pub-id></mixed-citation></ref><ref id="pone.0059525-He1"><label>29</label><mixed-citation publication-type="journal">
<article-title>He X, Szewczyk P, Karyakin A, Evin M, Hong WX, et al. Structure of a cation-bound multidrug and toxic compound extrusion transporter</article-title>. <source>Nature</source>
<volume>467</volume>: <fpage>991</fpage>&#x02013;<lpage>994</lpage>.<pub-id pub-id-type="pmid">20861838</pub-id></mixed-citation></ref><ref id="pone.0059525-Morita2"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Kataoka</surname><given-names>A</given-names></name>, <name><surname>Shiota</surname><given-names>S</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>2000</year>) <article-title>NorM of <italic>Vibrio parahaemolyticus</italic> is an Na(+)-driven multidrug efflux pump</article-title>. <source>J Bacteriol</source>
<volume>182</volume>: <fpage>6694</fpage>&#x02013;<lpage>6697</lpage>.<pub-id pub-id-type="pmid">11073914</pub-id></mixed-citation></ref><ref id="pone.0059525-Huda1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Huda</surname><given-names>MN</given-names></name>, <name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>2001</year>) <article-title>Na<sup>+</sup>-driven multidrug efflux pump VcmA from <italic>Vibrio cholerae</italic> non-O1, a non-halophilic bacterium</article-title>. <source>FEMS Microbiol Lett</source>
<volume>203</volume>: <fpage>235</fpage>&#x02013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">11583854</pub-id></mixed-citation></ref><ref id="pone.0059525-Chen1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Huda</surname><given-names>MN</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from <italic>Vibrio parahaemolyticus</italic>
</article-title>. <source>J Bacteriol</source>
<volume>184</volume>: <fpage>572</fpage>&#x02013;<lpage>576</lpage>.<pub-id pub-id-type="pmid">11751837</pub-id></mixed-citation></ref><ref id="pone.0059525-Huda2"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Huda</surname><given-names>MN</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Gene cloning and characterization of VcrM, a Na<sup>+</sup>-coupled multidrug efflux pump, from <italic>Vibrio cholerae</italic> non-O1</article-title>. <source>Microbiol Immunol</source>
<volume>47</volume>: <fpage>419</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">12906102</pub-id></mixed-citation></ref><ref id="pone.0059525-Xu1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>XJ</given-names></name>, <name><surname>Su</surname><given-names>XZ</given-names></name>, <name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Molecular cloning and characterization of the HmrM multidrug efflux pump from <italic>Haemophilus influenzae</italic> Rd</article-title>. <source>Microbiol Immunol</source>
<volume>47</volume>: <fpage>937</fpage>&#x02013;<lpage>943</lpage>.<pub-id pub-id-type="pmid">14695443</pub-id></mixed-citation></ref><ref id="pone.0059525-Long1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Long</surname><given-names>F</given-names></name>, <name><surname>Rouquette-Loughlin</surname><given-names>C</given-names></name>, <name><surname>Shafer</surname><given-names>WM</given-names></name>, <name><surname>Yu</surname><given-names>EW</given-names></name> (<year>2008</year>) <article-title>Functional cloning and characterization of the multidrug efflux pumps NorM from <italic>Neisseria gonorrhoeae</italic> and YdhE from <italic>Escherichia coli</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>52</volume>: <fpage>3052</fpage>&#x02013;<lpage>3060</lpage>.<pub-id pub-id-type="pmid">18591276</pub-id></mixed-citation></ref><ref id="pone.0059525-Berns1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Berns</surname><given-names>KI</given-names></name>, <name><surname>Thomas</surname><given-names>CA</given-names><suffix>Jr</suffix></name> (<year>1965</year>) <article-title>Isolation of High Molecular Weight DNA from <italic>Hemophilus Influenzae</italic>
</article-title>. <source>J Mol Biol</source>
<volume>11</volume>: <fpage>476</fpage>&#x02013;<lpage>490</lpage>.<pub-id pub-id-type="pmid">14267270</pub-id></mixed-citation></ref><ref id="pone.0059525-Tanaka1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Tanaka</surname><given-names>S</given-names></name>, <name><surname>Lerner</surname><given-names>SA</given-names></name>, <name><surname>Lin</surname><given-names>EC</given-names></name> (<year>1967</year>) <article-title>Replacement of a phosphoenolpyruvate-dependent phosphotransferase by a nicotinamide adenine dinucleotide-linked dehydrogenase for the utilization of mannitol</article-title>. <source>J Bacteriol</source>
<volume>93</volume>: <fpage>642</fpage>&#x02013;<lpage>648</lpage>.<pub-id pub-id-type="pmid">4289962</pub-id></mixed-citation></ref><ref id="pone.0059525-Lee1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>EW</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Huda</surname><given-names>MN</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Functional cloning and expression of <italic>emeA</italic>, and characterization of EmeA, a multidrug efflux pump from <italic>Enterococcus faecalis</italic>
</article-title>. <source>Biol Pharm Bull</source>
<volume>26</volume>: <fpage>266</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">12576692</pub-id></mixed-citation></ref><ref id="pone.0059525-Lopilato1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Lopilato</surname><given-names>J</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name>, <name><surname>Wilson</surname><given-names>TH</given-names></name> (<year>1978</year>) <article-title>Role of Na<sup>+</sup> and Li<sup>+</sup> in thiomethylgalactoside transport by the melibiose transport system of <italic>Escherichia coli</italic>
</article-title>. <source>J Bacteriol</source>
<volume>134</volume>: <fpage>147</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">25882</pub-id></mixed-citation></ref><ref id="pone.0059525-Tsuchiya1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Tsuchiya</surname><given-names>T</given-names></name>, <name><surname>Wilson</surname><given-names>TH</given-names></name> (<year>1978</year>) <article-title>Cation-sugar cotransport in the melibiose transport system of <italic>Escherichia coli</italic>
</article-title>. <source>Membr Biochem</source>
<volume>2</volume>: <fpage>63</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">45782</pub-id></mixed-citation></ref><ref id="pone.0059525-Tsuchiya2"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Tsuchiya</surname><given-names>T</given-names></name>, <name><surname>Raven</surname><given-names>J</given-names></name>, <name><surname>Wilson</surname><given-names>TH</given-names></name> (<year>1977</year>) <article-title>Co-transport of Na<sup>+</sup> and methul-beta-D-thiogalactopyranoside mediated by the melibiose transport system of <italic>Escherichia coli</italic>
</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>76</volume>: <fpage>26</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">17404</pub-id></mixed-citation></ref><ref id="pone.0059525-Spizizen1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Spizizen</surname><given-names>J</given-names></name> (<year>1958</year>) <article-title>Transformation of biochemically deficient strains of <italic>Bacillus subtilis</italic> by deoxyribonucleate</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>44</volume>: <fpage>1072</fpage>&#x02013;<lpage>1078</lpage>.<pub-id pub-id-type="pmid">16590310</pub-id></mixed-citation></ref><ref id="pone.0059525-Ochi1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Ochi</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>JY</given-names></name>, <name><surname>Tanaka</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>, <name><surname>Masuda</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Inactivation of KsgA, a 16 S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>53</volume>: <fpage>193</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">19001112</pub-id></mixed-citation></ref><ref id="pone.0059525-Hoskins1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Hoskins</surname><given-names>J</given-names></name>, <name><surname>Alborn</surname><given-names>WE</given-names><suffix>Jr</suffix></name>, <name><surname>Arnold</surname><given-names>J</given-names></name>, <name><surname>Blaszczak</surname><given-names>LC</given-names></name>, <name><surname>Burgett</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Genome of the bacterium <italic>Streptococcus pneumoniae</italic> strain R6</article-title>. <source>J Bacteriol</source>
<volume>183</volume>: <fpage>5709</fpage>&#x02013;<lpage>5717</lpage>.<pub-id pub-id-type="pmid">11544234</pub-id></mixed-citation></ref><ref id="pone.0059525-Turnbough1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Turnbough</surname><given-names>CL</given-names><suffix>Jr</suffix></name>, <name><surname>Switzer</surname><given-names>RL</given-names></name> (<year>2008</year>) <article-title>Regulation of pyrimidine biosynthetic gene expression in bacteria: repression without repressors</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>72</volume>: <fpage>266</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">18535147</pub-id></mixed-citation></ref><ref id="pone.0059525-Huang1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>M</given-names></name>, <name><surname>Oppermann-Sanio</surname><given-names>FB</given-names></name>, <name><surname>Steinbuchel</surname><given-names>A</given-names></name> (<year>1999</year>) <article-title>Biochemical and molecular characterization of the <italic>Bacillus subtilis</italic> acetoin catabolic pathway</article-title>. <source>J Bacteriol</source>
<volume>181</volume>: <fpage>3837</fpage>&#x02013;<lpage>3841</lpage>.<pub-id pub-id-type="pmid">10368162</pub-id></mixed-citation></ref><ref id="pone.0059525-Omote1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Omote</surname><given-names>H</given-names></name>, <name><surname>Hiasa</surname><given-names>M</given-names></name>, <name><surname>Matsumoto</surname><given-names>T</given-names></name>, <name><surname>Otsuka</surname><given-names>M</given-names></name>, <name><surname>Moriyama</surname><given-names>Y</given-names></name> (<year>2006</year>) <article-title>The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations</article-title>. <source>Trends Pharmacol Sci</source>
<volume>27</volume>: <fpage>587</fpage>&#x02013;<lpage>593</lpage>.<pub-id pub-id-type="pmid">16996621</pub-id></mixed-citation></ref><ref id="pone.0059525-Neyfakh1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Neyfakh</surname><given-names>AA</given-names></name> (<year>1992</year>) <article-title>The multidrug efflux transporter of <italic>Bacillus subtilis</italic> is a structural and functional homolog of the Staphylococcus NorA protein</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>36</volume>: <fpage>484</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">1605617</pub-id></mixed-citation></ref><ref id="pone.0059525-Masaoka1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Masaoka</surname><given-names>Y</given-names></name>, <name><surname>Ueno</surname><given-names>Y</given-names></name>, <name><surname>Morita</surname><given-names>Y</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>A two-component multidrug efflux pump, EbrAB, in <italic>Bacillus subtilis</italic>
</article-title>. <source>J Bacteriol</source>
<volume>182</volume>: <fpage>2307</fpage>&#x02013;<lpage>2310</lpage>.<pub-id pub-id-type="pmid">10735876</pub-id></mixed-citation></ref><ref id="pone.0059525-Ahmed1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Ahmed</surname><given-names>M</given-names></name>, <name><surname>Lyass</surname><given-names>L</given-names></name>, <name><surname>Markham</surname><given-names>PN</given-names></name>, <name><surname>Taylor</surname><given-names>SS</given-names></name>, <name><surname>Vazquez-Laslop</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>Two highly similar multidrug transporters of <italic>Bacillus subtilis</italic> whose expression is differentially regulated</article-title>. <source>J Bacteriol</source>
<volume>177</volume>: <fpage>3904</fpage>&#x02013;<lpage>3910</lpage>.<pub-id pub-id-type="pmid">7608059</pub-id></mixed-citation></ref><ref id="pone.0059525-Steinfels1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Steinfels</surname><given-names>E</given-names></name>, <name><surname>Orelle</surname><given-names>C</given-names></name>, <name><surname>Fantino</surname><given-names>JR</given-names></name>, <name><surname>Dalmas</surname><given-names>O</given-names></name>, <name><surname>Rigaud</surname><given-names>JL</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Characterization of YvcC (BmrA), a multidrug ABC transporter constitutively expressed in <italic>Bacillus subtilis</italic>
</article-title>. <source>Biochemistry</source>
<volume>43</volume>: <fpage>7491</fpage>&#x02013;<lpage>7502</lpage>.<pub-id pub-id-type="pmid">15182191</pub-id></mixed-citation></ref><ref id="pone.0059525-Tsuge1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Tsuge</surname><given-names>K</given-names></name>, <name><surname>Ohata</surname><given-names>Y</given-names></name>, <name><surname>Shoda</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Gene <italic>yerP</italic>, involved in surfactin self-resistance in <italic>Bacillus subtilis</italic>
</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>45</volume>: <fpage>3566</fpage>&#x02013;<lpage>3573</lpage>.<pub-id pub-id-type="pmid">11709341</pub-id></mixed-citation></ref><ref id="pone.0059525-Ohki1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Ohki</surname><given-names>R</given-names></name>, <name><surname>Murata</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>
<italic>bmr3</italic>, a third multidrug transporter gene of <italic>Bacillus subtilis</italic>
</article-title>. <source>J Bacteriol</source>
<volume>179</volume>: <fpage>1423</fpage>&#x02013;<lpage>1427</lpage>.<pub-id pub-id-type="pmid">9023234</pub-id></mixed-citation></ref><ref id="pone.0059525-Kuroda2"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Shimamoto</surname><given-names>T</given-names></name>, <name><surname>Inaba</surname><given-names>K</given-names></name>, <name><surname>Tsuda</surname><given-names>M</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>1994</year>) <article-title>Properties and sequence of the NhaA Na<sup>+</sup>/H<sup>+</sup> antiporter of <italic>Vibrio parahaemolyticus</italic>
</article-title>. <source>J Biochem</source>
<volume>116</volume>: <fpage>1030</fpage>&#x02013;<lpage>1038</lpage>.<pub-id pub-id-type="pmid">7896730</pub-id></mixed-citation></ref><ref id="pone.0059525-MortierBarriere1"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Mortier-Barriere</surname><given-names>I</given-names></name>, <name><surname>de Saizieu</surname><given-names>A</given-names></name>, <name><surname>Claverys</surname><given-names>JP</given-names></name>, <name><surname>Martin</surname><given-names>B</given-names></name> (<year>1998</year>) <article-title>Competence-specific induction of <italic>recA</italic> is required for full recombination proficiency during transformation in <italic>Streptococcus pneumoniae</italic>
</article-title>. <source>Mol Microbiol</source>
<volume>27</volume>: <fpage>159</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">9466264</pub-id></mixed-citation></ref><ref id="pone.0059525-Tocci1"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Tocci</surname><given-names>N</given-names></name>, <name><surname>Iannelli</surname><given-names>F</given-names></name>, <name><surname>Bidossi</surname><given-names>A</given-names></name>, <name><surname>Ciusa</surname><given-names>ML</given-names></name>, <name><surname>Decorosi</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Functional Analysis of Pneumococcal Drug Efflux Pumps Associates the MATE DinF Transporter with Quinolone Susceptibility</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>57</volume>: <fpage>248</fpage>&#x02013;<lpage>253</lpage>.<pub-id pub-id-type="pmid">23114782</pub-id></mixed-citation></ref><ref id="pone.0059525-Brown1"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Brown</surname><given-names>MH</given-names></name>, <name><surname>Paulsen</surname><given-names>IT</given-names></name>, <name><surname>Skurray</surname><given-names>RA</given-names></name> (<year>1999</year>) <article-title>The multidrug efflux protein NorM is a prototype of a new family of transporters</article-title>. <source>Mol Microbiol</source>
<volume>31</volume>: <fpage>394</fpage>&#x02013;<lpage>395</lpage>.<pub-id pub-id-type="pmid">9987140</pub-id></mixed-citation></ref><ref id="pone.0059525-McAleese1"><label>58</label><mixed-citation publication-type="journal">
<name><surname>McAleese</surname><given-names>F</given-names></name>, <name><surname>Petersen</surname><given-names>P</given-names></name>, <name><surname>Ruzin</surname><given-names>A</given-names></name>, <name><surname>Dunman</surname><given-names>PM</given-names></name>, <name><surname>Murphy</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived <italic>Staphylococcus aureus</italic> mutants to tigecycline</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>: <fpage>1865</fpage>&#x02013;<lpage>1871</lpage>.<pub-id pub-id-type="pmid">15855508</pub-id></mixed-citation></ref><ref id="pone.0059525-Brown2"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Brown</surname><given-names>DG</given-names></name>, <name><surname>Swanson</surname><given-names>JK</given-names></name>, <name><surname>Allen</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Two host-induced <italic>Ralstonia solanacearum</italic> genes, <italic>acrA</italic> and <italic>dinF</italic>, encode multidrug efflux pumps and contribute to bacterial wilt virulence</article-title>. <source>Appl Environ Microbiol</source>
<volume>73</volume>: <fpage>2777</fpage>&#x02013;<lpage>2786</lpage>.<pub-id pub-id-type="pmid">17337552</pub-id></mixed-citation></ref><ref id="pone.0059525-MunozElias1"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Munoz-Elias</surname><given-names>EJ</given-names></name>, <name><surname>Marcano</surname><given-names>J</given-names></name>, <name><surname>Camilli</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Isolation of <italic>Streptococcus pneumoniae</italic> biofilm mutants and their characterization during nasopharyngeal colonization</article-title>. <source>Infect Immun</source>
<volume>76</volume>: <fpage>5049</fpage>&#x02013;<lpage>5061</lpage>.<pub-id pub-id-type="pmid">18794289</pub-id></mixed-citation></ref><ref id="pone.0059525-Su1"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Su</surname><given-names>XZ</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>AbeM, an H<sup>+</sup>-coupled <italic>Acinetobacter baumannii</italic> multidrug efflux pump belonging to the MATE family of transporters</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>: <fpage>4362</fpage>&#x02013;<lpage>4364</lpage>.<pub-id pub-id-type="pmid">16189122</pub-id></mixed-citation></ref><ref id="pone.0059525-Murata1"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Murata</surname><given-names>T</given-names></name>, <name><surname>Kawano</surname><given-names>M</given-names></name>, <name><surname>Igarashi</surname><given-names>K</given-names></name>, <name><surname>Yamato</surname><given-names>I</given-names></name>, <name><surname>Kakinuma</surname><given-names>Y</given-names></name> (<year>2001</year>) <article-title>Catalytic properties of Na(+)-translocating V-ATPase in <italic>Enterococcus hirae</italic>
</article-title>. <source>Biochim Biophys Acta</source>
<volume>1505</volume>: <fpage>75</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">11248190</pub-id></mixed-citation></ref><ref id="pone.0059525-Kakinuma1"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Kakinuma</surname><given-names>Y</given-names></name> (<year>1987</year>) <article-title>Sodium/proton antiporter in <italic>Streptococcus faecalis</italic>
</article-title>. <source>J Bacteriol</source>
<volume>169</volume>: <fpage>3886</fpage>&#x02013;<lpage>3890</lpage>.<pub-id pub-id-type="pmid">2442134</pub-id></mixed-citation></ref><ref id="pone.0059525-Russell1"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Russell</surname><given-names>JB</given-names></name>, <name><surname>Strobel</surname><given-names>HJ</given-names></name>, <name><surname>Driessen</surname><given-names>AJ</given-names></name>, <name><surname>Konings</surname><given-names>WN</given-names></name> (<year>1988</year>) <article-title>Sodium-dependent transport of neutral amino acids by whole cells and membrane vesicles of <italic>Streptococcus bovis</italic>, a ruminal bacterium</article-title>. <source>J Bacteriol</source>
<volume>170</volume>: <fpage>3531</fpage>&#x02013;<lpage>3536</lpage>.<pub-id pub-id-type="pmid">3136141</pub-id></mixed-citation></ref><ref id="pone.0059525-Utsugi1"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Utsugi</surname><given-names>J</given-names></name>, <name><surname>Inaba</surname><given-names>K</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Tsuda</surname><given-names>M</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>1998</year>) <article-title>Cloning and sequencing of a novel Na<sup>+</sup>/H<sup>+</sup> antiporter gene from <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Biochim Biophys Acta</source>
<volume>1398</volume>: <fpage>330</fpage>&#x02013;<lpage>334</lpage>.<pub-id pub-id-type="pmid">9655928</pub-id></mixed-citation></ref><ref id="pone.0059525-Pinner1"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Pinner</surname><given-names>E</given-names></name>, <name><surname>Padan</surname><given-names>E</given-names></name>, <name><surname>Schuldiner</surname><given-names>S</given-names></name> (<year>1992</year>) <article-title>Cloning, sequencing, and expression of the <italic>nhaB</italic> gene, encoding a Na<sup>+</sup>/H<sup>+</sup> antiporter in <italic>Escherichia coli</italic>
</article-title>. <source>J Biol Chem</source>
<volume>267</volume>: <fpage>11064</fpage>&#x02013;<lpage>11068</lpage>.<pub-id pub-id-type="pmid">1317851</pub-id></mixed-citation></ref><ref id="pone.0059525-Hiramatsu1"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Hiramatsu</surname><given-names>T</given-names></name>, <name><surname>Kodama</surname><given-names>K</given-names></name>, <name><surname>Kuroda</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>1998</year>) <article-title>A putative multisubunit Na<sup>+</sup>/H<sup>+</sup> antiporter from <italic>Staphylococcus aureus</italic>
</article-title>. <source>J Bacteriol</source>
<volume>180</volume>: <fpage>6642</fpage>&#x02013;<lpage>6648</lpage>.<pub-id pub-id-type="pmid">9852009</pub-id></mixed-citation></ref><ref id="pone.0059525-Collins1"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Collins</surname><given-names>JF</given-names></name>, <name><surname>Honda</surname><given-names>T</given-names></name>, <name><surname>Knobel</surname><given-names>S</given-names></name>, <name><surname>Bulus</surname><given-names>NM</given-names></name>, <name><surname>Conary</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1993</year>) <article-title>Molecular cloning, sequencing, tissue distribution, and functional expression of a Na<sup>+</sup>/H<sup>+</sup> exchanger (NHE-2)</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>90</volume>: <fpage>3938</fpage>&#x02013;<lpage>3942</lpage>.<pub-id pub-id-type="pmid">7683411</pub-id></mixed-citation></ref><ref id="pone.0059525-Ogawa1"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Ogawa</surname><given-names>W</given-names></name>, <name><surname>Kim</surname><given-names>YM</given-names></name>, <name><surname>Mizushima</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>T</given-names></name> (<year>1998</year>) <article-title>Cloning and expression of the gene for the Na<sup>+</sup>-coupled serine transporter from <italic>Escherichia coli</italic> and characteristics of the transporter</article-title>. <source>J Bacteriol</source>
<volume>180</volume>: <fpage>6749</fpage>&#x02013;<lpage>6752</lpage>.<pub-id pub-id-type="pmid">9852024</pub-id></mixed-citation></ref><ref id="pone.0059525-MacLeod1"><label>70</label><mixed-citation publication-type="journal">
<name><surname>MacLeod</surname><given-names>PR</given-names></name>, <name><surname>MacLeod</surname><given-names>RA</given-names></name> (<year>1992</year>) <article-title>Identification and sequence of a Na(+)-linked gene from the marine bacterium <italic>Alteromonas haloplanktis</italic> which functionally complements the <italic>dagA</italic> gene of <italic>Escherichia coli</italic>
</article-title>. <source>Mol Microbiol</source>
<volume>6</volume>: <fpage>2673</fpage>&#x02013;<lpage>2681</lpage>.<pub-id pub-id-type="pmid">1447975</pub-id></mixed-citation></ref></ref-list></back></article>